Andrea Xuefen Bulow – EMERSON EQUITY LLC Broker Has An Investor Complaint – May Recover Investor Losses
EMERSON EQUITY LLC Broker, Andrea Xuefen Bulow Has An Investor Complaint.
ANDREA XUEFEN OU, XUEFEN OU
CRD#: 30716485
Call 800-500-4442 if you think that you have received unsuitable investment recommendations from your adviser.
Andrea Xuefen Bulow (CRD#: 30716485), a broker for EMERSON EQUITY LLC in SAN MATEO, CA, has an investor complaint. According to Bulow’s FINRA BrokerCheck report, claimant alleges Violations of Federal Securities Laws; Violations of California Securities Laws; California unfair, unlawful, and fraudulent business practices, Violation of California’s financial elder abuse law; Breach of contract; Common law fraud; Breach of fiduciary duty; Negligence and gross negligence. purchase made 05/2019.
The complainant is requesting $165,000.00 for alleged damages.

EMERSON EQUITY LLC Broker, Andrea Xuefen Bulow Has An Investor Complaint.
Goodman & Nekvasil, P.A., is investigating brokers who may have unsuitably recommended investments to their clients.
St. Petersburg, Florida law firm Goodman & Nekvasil, P.A., has a national practice representing victimized investors. The firm continues to investigate brokerage firms that placed elderly retirees and other conservative investors in unsuitable investments.
Goodman & Nekvasil, P.A., has filed numerous cases against brokerage firms selling high-risk investments and has recovered more than $500 million dollars on behalf of victimized investors.
We allege in these cases that these investment recommendations were unsuitable for our clients in view of their financial situation, needs and investment objectives.
There is no charge for an evaluation of your case. We handle our cases on a contingency fee basis. This means that unless we recover money for you, we charge no attorney’s fee.
If you incurred losses on your investment and would like your case evaluated by a securities attorney, please contact us.
Some of the information in this blog post was obtained from FINRA on 6/9/25. If you believe this information was reported incorrectly, please contact our firm: 1-800-500-4442.

